Wednesday, November 25, 2009, 12:42pm SGT - The Singapore stock market closes in 4 hours and 18 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Array BioPharma, Inc. (ARRY)

At 5:00AM SGT: 1.93 USD  Down 0.01 (0.52%)  
 MORE ON ARRY 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Array BioPharma Inc. (NGM:ARRY) Delayed quote dataEdit
After Hours: 1.93 Down 0.00 (0.02%) as of 5:16am SGT on 11/25/09
Last Trade:1.93 USD
Trade Time:5:00AM SGT
Change:Down 0.01 (0.52%)
Prev Close:1.94
Open:1.93
Bid:1.01 x 100
Ask:2.83 x 100
1y Target Est:5.66
Day's Range:1.90 - 1.96
52wk Range:1.68 - 4.68
Volume:111,905
Avg Vol (3m):399,459
Market Cap:95.17M
P/E (ttm):N/A
EPS (ttm):-2.48
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ARRY to Portfolio   Download Data

 HEADLINES 
•Array BioPharma to Present at the Piper Jaffray Healthcare Conference
Business Wire (Tue 1:59am)
•ARRAY BIOPHARMA INC Financials
EDGAR Online Financials (Fri, Nov 6)
•HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 5
at Reuters (Fri, Nov 6)
•Array Biopharma upgraded by UBS
Briefing.com (Thu, Nov 5)
•ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal
EDGAR Online (Wed, Nov 4)
•Array BioPharma Inc. F1Q10 (Quarter Ended June 30, 2010) Earnings Call Transcript
at Seeking Alpha (Wed, Nov 4)
•Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today
CCBN (Tue, Nov 3)
•ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 3)
•Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
Business Wire (Tue, Nov 3)
•Q1 2010 Array BioPharma Inc. Earnings Release - After Market Close
CCBN (Mon, Nov 2)
More Headlines for ARRY...
 ANALYST 
EPS Est (next year) (Jun-10) :-2.00
EPS Est (in 2 years) (Jun-11) :-1.79
Avg Rec (current)*:2.1
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer, inflammatory, and metabolic diseases in North America, Europe, and Asia Pacific.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices